0001209191-18-038984.txt : 20180621 0001209191-18-038984.hdr.sgml : 20180621 20180621172023 ACCESSION NUMBER: 0001209191-18-038984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180620 FILED AS OF DATE: 20180621 DATE AS OF CHANGE: 20180621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LASEZKAY GEORGE M CENTRAL INDEX KEY: 0001020514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 18912534 MAIL ADDRESS: STREET 1: 1301 SECOND AVE., SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-20 0 0001539029 Clearside Biomedical, Inc. CLSD 0001020514 LASEZKAY GEORGE M C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 0 0 0 Stock Option (right to buy) 10.74 2018-06-20 4 A 0 11250 0.00 A 2028-06-19 Common Stock 11250 11250 D The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2019. /s/ Brian F. Leaf, Attorney-in-Fact 2018-06-21